A-7.1) Industry Clinical Trial Contract

Review date: 
February 08, 2018
Responsible office: 
Office of Sponsored Research


Primary sponsor is a for-profit entity and terms are defined by contract.

An award for the controlled, clinical testing in human subjects of Investigational New Drugs (INDs), Investigational Devices (IDEs), treatments, or diagnostics, or comparisons of approved drugs, devices, treatments, or diagnostics, to assess their safety, efficacy, benefits, costs, adverse reactions, and/or outcomes. Such studies may be conducted under an industry-developed protocol or an investigator- developed protocol.

A type of interventional or clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. The assignments are determined by the study's protocol. Participants may receive diagnostic, therapeutic, or other types of interventions.